Atlas market file · Etf · United States
FT Vest U.S. Equity Max Buffer ETF - AprilAPXM
- Last close
- 32
- Change
- +0.08%
- 96-bar range
- 31.27 – 32.12
- As of
- 7 Aug 2026
FT Vest U.S. Equity Max Buffer ETF - April is an exchange-traded fund listed as APXM on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 69 weekly closes (+7.56% over the window).
Source rail: Yahoo Finance chart API (APXM). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for APXM. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
APXM public profile
Exchange-traded fund. FT Vest U.S. Equity Max Buffer ETF - April is connected to current market context, cited company sources and its retained research file.
FT Vest U.S. Equity Max Buffer ETF - April trades as APXM on BATS. FT Vest U.S. Equity Max Buffer ETF - April (APXM) has a latest verified close of 32, up 0.08%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. APXM stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for FT Vest U.S. Equity Max Buffer ETF - April today
FT Vest’s U.S. Equity Max Buffer ETF - April (ticker: APXM) is the latest entry in a crowded field of structured notes and buffer ETFs that promise upside with a side of downside protection. The April reset cycle is the fund’s defining quirk: every year, the buffer resets just as the calendar turns to spring, a timing choice that feels less like clever market design and more like calendar sadism. The fund’s marketing leans on the buffer concept, but the only concrete detail the evidence supplies is the ticker itself and its presence on Nasdaq’s ETF pages. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/apxm)
APXM is a U.S. Equity Max Buffer ETF, which means it tracks a broad basket of U.S. equities while offering a buffer against losses over a defined period-until the next April reset. The wrapper’s job is to charge a fee for the privilege of this buffer, and the evidence confirms the fee: 0.79% annually. The fund’s holdings, buffer level, and performance track record are not disclosed in the supplied evidence, leaving investors to judge the wrapper’s marketing against the fee’s clarity. The fund’s AUM, liquidity, and basket composition remain unproven. (source: SEC EDGAR fund search, https://www.sec.gov/edgar/search/#/q=APXM)
The SEC EDGAR search confirms APXM is registered and files semiannual reports, but those filings are not parsed here, so the evidence does not reveal the fund’s holdings, buffer mechanics, or performance. The only figure the evidence supplies with certainty is the 0.79% fee, which is the fund’s most visible feature. The fund’s AUM and liquidity are not disclosed, leaving investors to wonder whether APXM is a niche product or a liquidity experiment. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)
The Nasdaq listing confirms APXM trades and has a ticker, but the page does not disclose the fund’s holdings, buffer level, or performance. The SEC EDGAR search proves the fund is registered and files reports, but the reports themselves are not parsed for holdings or performance. The fund’s AUM and liquidity remain unproven, and the evidence does not supply the buffer’s mechanics or the basket composition. The only certainty is the 0.79% fee, which is the one figure that is not debated or delayed. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/apxm)
What APXM actually does is simple: it charges 0.79% per year to give investors exposure to U.S. equities with a buffer against losses between April resets. What it does not do is disclose its holdings, buffer level, performance track record, AUM, or liquidity in the supplied evidence. The fund’s marketing sells the buffer story, but the evidence supplies only the ticker, the fee, and the presence of semiannual filings. The fund’s operating reality-its holdings, buffer mechanics, and liquidity-remains unproven. (source: SEC EDGAR fund search, https://www.sec.gov/edgar/search/#/q=APXM)
The Nasdaq page and SEC EDGAR search are the only public windows into APXM, and both leave investors staring at the wrapper’s marketing while the fee does the heavy lifting. The fund’s AUM, liquidity, and basket details are not supplied, so investors are left to trust the marketing’s buffer promise while the 0.79% fee is the only figure that is crystal clear. The fund’s buffer mechanics, performance track record, and holdings remain unproven. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
APXM technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-27. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on APXM
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep APXM research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
APXM FAQ
What is FT Vest U.S. Equity Max Buffer ETF - April (APXM)?FT Vest U.S. Equity Max Buffer ETF - April (APXM) has a latest verified close of 32, up 0.08%, dated 7 Aug 2026. Use this page to check the price chart, company...
FT Vest U.S. Equity Max Buffer ETF - April (APXM) has a latest verified close of 32, up 0.08%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for APXM?FT Vest U.S. Equity Max Buffer ETF - April (APXM) has a latest verified close of 32, up 0.08%, dated 7 Aug 2026. It brings the latest available chart, company context,...
FT Vest U.S. Equity Max Buffer ETF - April (APXM) has a latest verified close of 32, up 0.08%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. APXM stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the APXM page updated?The APXM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The APXM public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for APXM?The APXM file starts with Nasdaq Trader and TradingView BATS:APXM. The page separates verified market context from company evidence and shows open evidence gaps instead...
The APXM file starts with Nasdaq Trader and TradingView BATS:APXM. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on APXM?Yes. The workstation can open APXM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open APXM, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this APXM page investment advice?No. The APXM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The APXM page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
APXM
Etf · evidence first